Average Co-Inventor Count = 10.70
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharma Aktiengesellschaft (12 from 378 patents)
2. Bayer Aktiengesellschaft (4 from 12,160 patents)
3. Johns Hopkins University (3,687 patents)
12 patents:
1. 12144865 - Antibody drug conjugates with enzymatically cleavable groups
2. 11685714 - Prodrugs of cytotoxic active agents having enzymatically cleavable groups
3. 11667675 - MASP inhibitory compounds and uses thereof
4. 11337973 - Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitors
5. 11136296 - Substituted-arylethyl-2-arylquinoline-4-carboxamides and use thereof
6. 11123439 - Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups
7. 10722501 - Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof
8. 10485880 - Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodies
9. 10479765 - Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents
10. 10189788 - Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents
11. 10117864 - Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof
12. 10022453 - Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)